Rash Acneiform
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities (NCT05378360) | Daewoong Pharmaceutical Co. LTD. | 2022-05-02 |
Track Rash Acneiform automatically
Every clearance here is in the API, with alerts when new ones post.